Delivery Order SPE2DB22D1106-SPE2DB25FEZT2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,630.28 to AmerisourceBergen Drug Corp for OFEV 100 mg capsules (60-count units) on July 23, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a $8,590.58 delivery order to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) on July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price contract represents a non-competitive set-aside and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of OFEV 150 mg capsules (60-count units) under a firm fixed-price arrangement. The contract, valued at $8,590.58, was competitively awarded without any set-aside designation and carries an ultimate completion date of August 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its...
- The Defense Logistics Agency awarded a $8,590.58 delivery order to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) under a firm fixed price contract. The award was made on July 21, 2025, with an ultimate completion date of August 11, 2025. The contract utilizes no set-aside designation and represents a competitive award to the pharmaceutical distributor, with performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $8,630.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OFEV (pirfenidone) 100 mg capsules (60-count unit) on July 21, 2025. The contract, which is expected to be completed by August 11, 2025, will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV (nintedanib) 150 mg capsules (60-count units) on July 18, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order represents a non-set-aside award, indicating it was competitively procured. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OFEV 100 mg capsules (60-count units) with a ceiling value of $8,630.28. This firm fixed price delivery order, issued on July 22, 2025, with an ultimate completion date of August 12, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, and performance will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,771.74 to AmerisourceBergen Drug Corp for the supply of OFEV (nintedanib) 150 mg capsules in quantities of 60 units. This is a firm fixed price delivery order with an ultimate completion date of August 14, 2025, and represents a non-set-aside competitive award. The work will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide OFEV 150 MG CAPSULE 60S, a pharmaceutical product, with a ceiling value of $7,905.56. The contract has an ultimate completion date of April 22, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of OFEV (nintedanib) 150 mg capsules in a quantity of 60 units, with a ceiling value of $8,590.58. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award to the prime contractor. The order is scheduled for completion by August 11, 2025, with performance taking place at the vendor's Corporate Office location in Conshohocken,...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZT2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $25,890.84 to AmerisourceBergen Drug Corp for OFEV 100 mg capsules (60-count units) on July 25, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order through its existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. This delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs, likely serving military healthcare systems and other government agencies through the DLA's Medical Supply Chain. AmerisourceBergen Drug Corp's portfolio encompasses a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The contractor's demonstrated capability to meet federal procurement requirements through open competition, combined with its strategic positioning as a prime vendor for multiple regions under the planned Pharmaceutical Prime Vendor Global Program Generation V initiative, underscores its critical role in supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.9k | 7/25/25 |